High Powered Stone Dusting vs. Fragmentation and Basketing at Time of Ureteroscopy
Prospective, Randomized Study to Assess Patient Satisfaction and Stone Free Effect of High Powered Stone Dusting vs. Fragmentation and Basketing at Time of Ureteroscopy
1 other identifier
interventional
168
1 country
1
Brief Summary
The purpose of this study is to determine the differences in stone free results, patient side effects, and patient satisfaction between dusting vs. basket extraction for kidney and ureteral stones (a kidney stone located in the tube between the kidney and bladder) 6 mm and greater in size undergoing ureteroscopic treatment. Dusting is when a laser is used to break a stone down into tiny fragments that are able to pass through the urine. Basket extraction is when a small wire basket is used to remove stone fragments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 28, 2021
CompletedFirst Submitted
Initial submission to the registry
August 6, 2021
CompletedFirst Posted
Study publicly available on registry
August 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 10, 2024
CompletedApril 30, 2026
July 1, 2025
1.9 years
August 6, 2021
April 26, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Stone free rate: clinical
patients with no clinical evidence of kidney stones on the treated side
6 weeks
Stone free rate: imaging
patients with no radiographic evidence of kidney stones on the treated side
6 weeks
Secondary Outcomes (4)
Patient quality of life- pain intensity
12 weeks
Patient quality of life- pain interference
12 weeks
Return to work
12 weeks
Daily activity level
12 weeks
Study Arms (2)
laser dusting
ACTIVE COMPARATORIn the "dusting" arm, the ureteroscope will be advanced into the kidney or ureter over an access wire without an access sheath in place. The identified stone will be dusted using a 200 micron Moses laser fiber at a setting of 0.3-0.6 J and 50-120 Hz using the Moses 2.0 laser system. Stone dusting will continue until the surgeon feels the fragments are all negligible in size and would be able to pass. One small piece will be extracted for analysis and the remainder will be left to pass spontaneously. If there is no evidence of injury or swelling of the ureter at the conclusion of the case a stent will be omitted.
basketing
ACTIVE COMPARATORIn the Basketing arm, a ureteral access sheath (UAS) will be placed per standard fashion. The ureteroscope will be introduced into the kidney and the stone fragmented at a setting of 0.8-1.0 J and 6-15 Hz. The resultant fragments will be basket extracted through the sheath for analysis. All fragments will be removed until no residual stone remains. At the time of UAS removal the ureter will be inspected. If there is no evidence of ureteral injury or swelling then a stent will be omitted.
Interventions
Dusting is when a laser is used to break a stone down into tiny fragments that are able to pass through the urine.
Basket extraction is when a small wire basket is used to remove stone fragments.
Eligibility Criteria
You may qualify if:
- \>18 years of age
- undergoing ureteroscopic stone extraction
- Stone size 6mm stones or greater and the location to mid ureter or higher
- Willing to sign informed consent form
- Able to read, understand, and complete patient questionnaires, and pain questionnaires
You may not qualify if:
- \< 18 years of age
- Inability to provide informed consent
- Concomitant surgery (i.e. Percutaneous nephrolithotomy, Holmium laser enucleation of the prostate
- Solitary kidney
- Nephrocalcinosis
- Members of vulnerable patient populations
- Patients without access to a phone that can receive txt messages
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amy Krambeck, MD
Northwestern University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Urology
Study Record Dates
First Submitted
August 6, 2021
First Posted
August 16, 2021
Study Start
July 28, 2021
Primary Completion
July 1, 2023
Study Completion
June 10, 2024
Last Updated
April 30, 2026
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share